Study directory

Depression studies

Compare studies and check their requirements with the research team.

6115studies shown

Showing 2,041-2,052 of 6,115

CompletedEUCTR 2007-000512-82

Optimal Duration of Olazapine Add-on therapy in Major Depression: A double-blind, placebo-controlled, randomized, Phase III, Pilot Study in parallel group Design

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: Germany
Sponsor: Charité Universitätsmedizin Berlin
Condition: Depression

View study

CompletedEUCTR 2008-003877-42

Relapse prevention in patients with major depression treated with electroconvulsive therapy using a fixed dose range of escitalopram compared to a fixed dose of nortriptyline (DUAG-7) A randomised ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: Denmark
Sponsor: Danish University Antidepressant Group (DUAG)
Condition: Depression

View study

CompletedEUCTR 2007-001335-54

SAFETY AND EFFICACY OF CIMICOXIB, A SELECTIVE COX-2 INHIBITOR, IN COMBINATION WITH SERTRALINE COMPARED TO SERTRALINE COMBINED WITH PLACEBO IN TREATMENT OF MAJOR DEPRESSION

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: Austria, Czechia, Germany
Sponsor: Affectis Pharmaceuticals AG
Condition: Depression

View study

CompletedEUCTR 2018-002947-27

Simvastatin add-on to Escitalopram in patients with comorbid obesity and major depression: A multicenter, randomized, double-blind, placebo-controlled trial

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: Germany
Sponsor: Charité – Universitätsmedizin Berlin
Condition: Depression

View study

CompletedEUCTR 2021-006800-34

The Role of Negr1 In modulating Neuroplasticity in major depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: Italy
Sponsor: FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO
Condition: Depression

View study

Recruitment unclearEUCTR 2020-001424-34

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF SAGE-217 IN THE TREATMENT OF ADULTS WITH SEVERE POSTPARTUM DEPRESSION

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: United Kingdom
Sponsor: Sage Therapeutics, Inc.
Condition: Depression

View study

Recruitment unclearEUCTR 2009-016463-10

Antidepressive response to add-on occupational therapy in patients with major depression: A randomized controlled multicentre trial

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: Germany
Sponsor: LWL University Hospital Bochum
Condition: Depression

View study

Recruitment unclearEUCTR 2007-006914-41

Differential responses to Cognitive Behavioural Analysis System of Psychotherapy (CBASP) versus escitalopram in chronic major depression with and without early trauma

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: Germany
Sponsor: Dept. of Psychiaty, University of Freiburg
Condition: Depression

View study

Recruitment unclearEUCTR 2007-000137-19

Metyrapone as additive treatment in patients with major depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands

Why is this study shown?

This study is directly about Depression.

Depression, SchizophreniaDrug

Countries: Netherlands
Sponsor: Leiden University Medical Center
Condition: Depression, Schizophrenia

View study

Recruitment unclearEUCTR 2014-001541-24

Neuroenhancement of Interpersonal Psychotherapy in Major Depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: Germany
Sponsor: University Medical Center Freiburg
Condition: Depression

View study

Recruitment unclearEUCTR 2008-000453-35

Open-label phase IIa pilot study exploring safety and potential efficacy of recombinant human erythropoietin in early mild Alzheimer Dementia and therapy-refractory Major Depression (“EPO-AD”)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany

Why is this study shown?

This study is directly about Depression.

DepressionBiological

Countries: Germany
Sponsor: Max-Planck-Institute of Experimental Medicine
Condition: Depression

View study

Recruitment unclearEUCTR 2022-000603-12

Oxytocin and reactivity to infant signals in mothers with postpartum depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: Netherlands
Sponsor: Radboud University
Condition: Depression

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.